Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,250 | 1,310 | 1,130 | 2,380 | 4,320 |
| Other current assets | 210 | 70 | 80 | 120 | 150 |
| TOTAL | $3,460 | $1,380 | $1,210 | $2,500 | $4,470 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 300 | 320 | 380 | 380 | 330 |
| TOTAL | $300 | $320 | $380 | $380 | $330 |
| Total Assets | $3,830 | $1,780 | $1,680 | $2,980 | $4,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 460 | 600 | 570 | 420 | 580 |
| Accrued Expenses | 520 | 360 | 460 | 530 | 530 |
| Other current liabilities | 0 | 1,630 | 0 | 0 | 0 |
| TOTAL | $980 | $2,600 | $1,310 | $1,400 | $1,710 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,010 | 2,100 | 2,120 | 900 | 2,700 |
| TOTAL | $6,010 | $2,100 | $2,120 | $900 | $2,700 |
| Total Liabilities | $7,000 | $4,700 | $3,430 | $2,300 | $4,420 |
| Shareholders' Equity | |||||
| Common Shares | 750 | 40 | 40 | 40 | 40 |
| Retained earnings | -37,140 | -35,160 | -33,850 | -31,260 | -31,300 |
| Other shareholders' equity | 0 | 10 | 10 | -10 | 0 |
| TOTAL | $-3,160 | $-2,920 | $-1,750 | $670 | $490 |
| Total Liabilities And Equity | $3,840 | $1,780 | $1,680 | $2,970 | $4,910 |